Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

Inclusion Criteria: * Able to understand written informed consent * Willing and able to comply with study requirements * Willing to comply with protocol-specified contraception requirements * Healthy male or non-pregnant, non-lactating female of non-childbearing potential per Investigator assessment. * Body mass index (BMI) of 18.0 to 30.0 kg/m\^2 at screening * Weight of at least 50 kg at screening Exclusion Criteria: * Serious adverse reaction or hypersensitivity to any drug or formulation excipients * History of clinically significant allergy requiring treatment * History of clinically significant cardiovascular, renal, hepatic, dermatological, chronic respiratory or gastrointestinal (GI) disease, neurological or psychiatric disorder * Any form of cancer within the 5 years before the first does of this study * History and/or symptoms of adrenal insufficiency * History of clinically significant GI disease * Condition or history of a condition that could be aggravated by glucocorticoid antagonism or glucocorticoid activation * History of additional risk factors for torsades de pointes * Poor venous access that limits phlebotomy * Clinically significant abnormal clinical chemistry, hematology or urinalysis * History or evidence of hypokalemia * Positive hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV Ab) or human immunodeficiency virus (HIV) 1 and 2 antibody results * Evidence of renal impairment at screening * Positive serum or highly sensitive urine …